CRP and metabolic syndrome: Animal studies have shown that magnesium deficiency induces inflammatory response [16]; randomized controlled trials further report that magnesium treatments significantly decrease concentrations of C-reactive protein (CRP) among patients with metabolic syndrome [17] or high risk of inflammation [18].